U.S. stocks closed higher Friday, with all three major indices finishing the week at fresh all-time peaks in the wake of Donald Trump's victory in the presidential election. Stocks rose at the end of their best week in 2024 amid solid consumer sentiment data and bets that newly elected President Donald Trump’s pro-growth agenda will keep fuelling Corporate America. More than $2 trillion was added to equities over the five sessions, helped by a $20 billion inflow to funds on Wednesday alone. Small-cap companies surged nearly 9%, banks rallied too and Bitcoin hit a fresh record. Behind the run-up is near-unalloyed optimism that Trump’s pro-growth promises — tax cuts and deregulation — will unlock another round of gains in an already flourishing economy, just as the Federal Reserve tilts toward an easy-money stance. China on Friday announced a five-year package totaling 10 trillion yuan ($1.4 trillion) to tackle local government debt problems, while signaling more economic support would come next year. US FDA has classified Biocon Biologics’ facilities at Biocon Park, Bengaluru, India, as Voluntary Action Indicated (VAI). REC eyes another Rs 5,000 crore fundraise through zero-coupon bonds Punjab & Sind Bank seeks bids to sell Rs 403 cr bad loans in 9 accounts Asian shares slipped Monday after China’s new economic support disappointed some investors and data showed persistent deflationary pressures. Nifty extended losses to a second session on Nov 08 after a rangebound zigzag move. It fell 0.21% to close at 24148.2. Investors need to be careful of trying to bottom fish and may look to take part profits in some stocks and raise cash as a sharp turnaround in sentiments does not seem nearby. The short-term trend of Nifty continues to be choppy, and this consolidation is likely to continue in the near term with a weak bias. The next lower supports to be watched around 23800 levels. Immediate resistance is placed at 24537 levels. Indian markets could open mildly higher, in line with mostly lower Asian markets today and despite positive US markets on Nov 08